Other
Transesophageal echocardiogram (TEE)
Transesophageal echocardiogram (TEE) is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruiting
Health Data Warehouse on Aortic Insufficiency
NCT06420895
completednot_applicable
Coronary Artery Assessement by TEE in Congenital Heart Disease
NCT04194502
completednot_applicable
Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
NCT02661529
Clinical Trials (3)
Showing 3 of 3 trials
NCT06420895
Health Data Warehouse on Aortic Insufficiency
NCT04194502Not Applicable
Coronary Artery Assessement by TEE in Congenital Heart Disease
NCT02661529Not Applicable
Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3